Home   |  Kontaktandmed   |  Asukohad
Safe Infusion Therapy (ET)
 

Kirjandus


AFS Cytostatics and other medications with permanent toxic effects [translation] Swedish Work Environment Agency 2005: 5


ASTM. D6978-05: Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs, American Society for Testing and Materials 2005


Crauste-Manciet S, Sessink PMJ, Ferrari S, Jomier JY, Brossard D. Environmental Contamination with Cytotoxic Drugs in Healthcare Using Positive Air Pressure Isolators. Ann Occup Hyg 2005; 49(7): 619–628
http://www.ncbi.nlm.nih.gov/pubmed/16126757


Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979; 1(8128): 1250–1251
http://www.ncbi.nlm.nih.gov/pubmed/87722


Flintoff JP. Thalidomide: the battle for compensation goes on. The Sunday Times. March 23, 2008
http://www.timesonline.co.uk/tol/life_and_style/health/article3602694.ece


Fransman W, Vermeulen R, Kromhout H. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pi lot study. Ann Occup Hyg 2004; 48(3): 237–244
http://www.ncbi.nlm.nih.gov/pubmed/15059800


Gielen K, Goossens A. Occupational allergic contact dermatitis from drugs in healthcare workers. Contact Dermatitis 2001; 45: 273–279
http://www.ncbi.nlm.nih.gov/pubmed/11722486


Health Counsel of the Neatherlands. Risk assessment of carcinogenic chemicals in the Neatherlands. Regul Toxicol Pharmacol 1994; 19: 14-30
http://www.ncbi.nlm.nih.gov/pubmed/8159812


Hemminki K, Kyyrönen P, Lindbohm M-L. Spontaneous abortions and malformation in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health 1985; 39: 141-147
http://www.ncbi.nlm.nih.gov/pubmed/3925060



Horner MJ, Ries LAG, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, Md, based on November 2008 SEER data submission, posted to the SEER website, 2009. Table I-21, US Prevalence Counts, Invasive Cancers Only, January 1, 2006, Using Different Tumor Inclusion Criteria. Accessed at http://seer.cancer.gov/csr/1975_2006/results_single/sect_01_table.21_2pgs.pdf on September 3, 2009


IARC Monographs on the Evaluation of Carcinogenic Risks to Humans - Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs 1987. Supplement 7; Volumes 1-42
http://www.ncbi.nlm.nih.gov/pubmed/3482203


IGBCE. Manteltarifvertrag 2000
http://www.ncbi.nlm.nih.gov/pubmed/2000


Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to antineoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace sur veys. Ann Occup Hyg 2000; 44(7): 551–560
http://www.ncbi.nlm.nih.gov/pubmed/11042258


Larson RR, Khazaeli MB,»Dillon HK. A New Monitoring Method Using Solid Sorbent Media for Evaluation of Airborne Cyclophosphamide and Other Antineoplastic Agents. Appl Occup Environ Hyg 2003; 18(2): 120-131
http://www.ncbi.nlm.nih.gov/pubmed/12519686


Macmillan cancer support website. A guide to benefits and financial help for people affected by cancer.
http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/costofcancer


Mälkönen T, Jolanki R, Alanko K, Luukkonen R, Aalto-Korte K, Lauerma A, Susitaival P. A 6-month follow-up study of 1048 patients diagnosed with an occupational skin disease. Contact Dermatitis 2009; 61(5): 261-8
http://www.ncbi.nlm.nih.gov/pubmed/19878240


Mason HJ, Morton J, Gar_ tt SJ, Iqbal S, Jones K. Cytotoxic drug contami nation on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 2003; 47(8): 681–685
http://www.ncbi.nlm.nih.gov/pubmed/14602675


McDiarmid MA, Egan T. Acute occupational exposure to antineoplastic agents. J Occup Med 1988; 30(12): 984–987
http://www.ncbi.nlm.nih.gov/pubmed/3230452


National Cancer Institute website (USA).
http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/costofcancer


Neal AdW, Wadden RA, Chiou WL. Exposure of hospital workers to airborne antineoplastic agents. Am J Hosp Pharm 1983; 40(4): 597-601
http://www.ncbi.nlm.nih.gov/pubmed/6846365


Nguyen TV, Theiss JC, Matney TS. Exposure of pharmacy personnel to muta genic antineoplastic drugs. Cancer Res 1982; 42: 4792–4796
http://www.ncbi.nlm.nih.gov/pubmed/6751527


NHS Careers website. http://www.nhscareers.nhs.uk/


NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. U.S. Department of Health and Human Services, Public Health Service, Centers form Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) 2004. Publication No. 2004-165
http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf


Paclitaxel SmPC. BMS 2010


QuapoS 3 Quality Standard for the Oncology Pharmacy Service with Commentary. Institute for Applied Healthcare Sciences (IFAHS e.V.) for the German Society of Oncology Pharmacy (DGOP e.V.). 2003
http://www.esop.li/downloads/library/Quapos-en-with-commentary.pdf


Rogers B, Emmett EA. Handling anti-neoplastic agents: urine mutagenicity in nurses. J Nurs Scholarsh 1987; 19: 108–113
http://www.ncbi.nlm.nih.gov/pubmed/3311973


Sarto F, Trevisan A, Tomanin R, Canova A, Fiorentino M. Chromosomal Aberrations, Sister Chromatid Exchanges, and Urinary Thioethers in Nurses Handling Antineoplastic Drugs. Am J Ind Med 1990; 18: 689495
http://www.ncbi.nlm.nih.gov/pubmed/2264567


Schmaus G, Schierl R, Funck S. Monitoring surface contamination by anti-neoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 2002; 59: 956–961
http://www.ncbi.nlm.nih.gov/pubmed/12040735


Selevan SG, Lindbohm M-L, Hornung RW, Hemminki K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med 1985; 313(19): 1173–1178
http://www.ncbi.nlm.nih.gov/pubmed/4058490


Sessink PJM, Van De Kerkhof MCA, Anzion RBM, Noordhoek J, Bos RP. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 1994; 49(3): 165–169
http://www.ncbi.nlm.nih.gov/pubmed/8185386


Sessink PJM, Kroese ED, van Kranen HJ, Bos RP. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health 1995; 67: 317-323
http://www.ncbi.nlm.nih.gov/pubmed/8543380


Skov T, Maarup B, Olsen J, Rørth M, Winthereik H, Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med 1992; 49: 855–861
http://www.ncbi.nlm.nih.gov/pubmed/1472444


Sotaniemi EA, Sutinen S, Arranto AJ, Sutinen S, Sotaniemi KA, Lehtola J, Pelkonen RO. Liver Damage in Nurses Handling Cytostatic Agents. Acta Med Scand 1983; 214: 181-9
http://www.ncbi.nlm.nih.gov/pubmed?term=Sotaniemi%20EA%2C%20Sutinen%20S%2C%20Arranto%20AJ%2C%20Sutinen%20S%2C%20Sotaniemi%20KA%2C%20Lehtola%20J%2C%20Pelkonen%20RO.%20Liver%20Damage%20in%20Nurses%20Handling%20Cytostatic%20Agents.%20Acta%20Med%20Scand%201983%3B%20214%3A%20181-9


Stücker I, Caillard J-F, Collin R, Gout M, Poyen D, Hémon D. Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health 1990; 16: 102–107
http://www.ncbi.nlm.nih.gov/pubmed/2353192


Ündeger Ü, Baþaran N, Kars A, Güç D. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay. Mutat Res 1999; 439: 277–285
http://www.ncbi.nlm.nih.gov/pubmed/10023083


Valanis BG, Vollmer WM, Labuhn KT, Glass AG. Ägedad sümptomid, mis seonduvad antineoplastiliste ravimite käsitsemisega medõdede seas. Cancer Nurs 1993a; 16(4): 288–295
http://www.ncbi.nlm.nih.gov/pubmed/8402605


Valanis BG, Vollmer WM, Labuhn KT, Glass AG. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am J Hosp Pharm 1993b; 50: 455–462
http://www.ncbi.nlm.nih.gov/pubmed/8442461


Valanis B, Vollmer WM, Steele P. Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med 1999; 41(8): 632–638
http://www.ncbi.nlm.nih.gov/pubmed/10457505


 

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Product images are for reference only. Please contact your country representative for product availability and information.